Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
6.82
+0.04 (0.59%)
At close: May 28, 2026, 4:00 PM EDT
6.82
0.00 (0.00%)
After-hours: May 28, 2026, 4:10 PM EDT
Fulcrum Therapeutics Market Cap
Fulcrum Therapeutics has a market cap or net worth of $454.44 million as of May 28, 2026. Its market cap has increased by 48.22% in one year.
Market Cap
454.44M
Enterprise Value
126.66M
1-Year Change
48.22%
Ranking
Category
Stock Price
$6.82
Market Cap Chart
Since July 18, 2019, Fulcrum Therapeutics's market cap has increased from $301.64M to $454.44M, an increase of 50.65%. That is a compound annual growth rate of 6.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 451.77M | -39.45% |
| Dec 31, 2025 | 746.12M | 194.32% |
| Dec 31, 2024 | 253.51M | -39.25% |
| Dec 29, 2023 | 417.30M | 10.13% |
| Dec 30, 2022 | 378.93M | -47.15% |
| Dec 31, 2021 | 716.95M | 124.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ocugen | 453.62M |
| Autolus Therapeutics | 452.44M |
| 4D Molecular Therapeutics | 449.58M |
| Neurogene | 437.87M |
| Sagimet Biosciences | 437.82M |
| ADC Therapeutics | 431.18M |
| Prelude Therapeutics | 429.47M |
| Ovid Therapeutics | 427.40M |